NOVO.B.DK

435.1

-1.46%↓

GMAB.DK

1,302

-0.19%↓

HLUNB.DK

35.98

-1.05%↓

ZEAL.DK

368.1

+3.11%↑

AMBUB.DK

97.85

-3.31%↓

NOVO.B.DK

435.1

-1.46%↓

GMAB.DK

1,302

-0.19%↓

HLUNB.DK

35.98

-1.05%↓

ZEAL.DK

368.1

+3.11%↑

AMBUB.DK

97.85

-3.31%↓

NOVO.B.DK

435.1

-1.46%↓

GMAB.DK

1,302

-0.19%↓

HLUNB.DK

35.98

-1.05%↓

ZEAL.DK

368.1

+3.11%↑

AMBUB.DK

97.85

-3.31%↓

NOVO.B.DK

435.1

-1.46%↓

GMAB.DK

1,302

-0.19%↓

HLUNB.DK

35.98

-1.05%↓

ZEAL.DK

368.1

+3.11%↑

AMBUB.DK

97.85

-3.31%↓

NOVO.B.DK

435.1

-1.46%↓

GMAB.DK

1,302

-0.19%↓

HLUNB.DK

35.98

-1.05%↓

ZEAL.DK

368.1

+3.11%↑

AMBUB.DK

97.85

-3.31%↓

Search

Coloplast A-S (Class B)

Atidarymo kaina

594.2 -2.27

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

593

Max

611.4

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-132M

912M

Pardavimai

-96M

6.9B

P/E

Sektoriaus vid.

30.208

50.291

Pelnas, tenkantis vienai akcijai

4.34

Dividendų pajamingumas

3.61

Pelno marža

13.16

Darbuotojai

16,741

EBITDA

2.2B

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+11.86% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

3.61%

2.40%

Kitas uždarbis

2025-08-19

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-19B

138B

Ankstesnė atidarymo kaina

596.47

Ankstesnė uždarymo kaina

594.2

Coloplast A-S (Class B) Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-06-30 21:26; UTC

Pagrindinės rinkos jėgos

AeroVironment Shares Slide on Stock, Notes Offerings

2025-06-30 16:50; UTC

Įsigijimai, susijungimai, perėmimai

BBVA Won't Withdraw Sabadell Offer

2025-06-30 23:43; UTC

Rinkos pokalbiai

Gold Edges Higher, Underpinned by Fed-Rate Cut Hopes -- Market Talk

2025-06-30 23:38; UTC

Rinkos pokalbiai

Nikkei May Fall as Yen Has Strengthened Amid Trade Uncertainty -- Market Talk

2025-06-30 23:38; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-06-30 23:03; UTC

Uždarbis

Boeing CFO Exit Is Latest Change in Chief Executive Kelly Ortberg's C-Suite -- Update

2025-06-30 22:50; UTC

Įsigijimai, susijungimai, perėmimai

Giant Eagle Closes Sale of Its GetGo Business to Alimentation Couche-Tard

2025-06-30 22:50; UTC

Uždarbis

Boeing Hires Former Lockheed Martin Executive to Succeed CFO Brian West -- Update

2025-06-30 21:26; UTC

Uždarbis

Berkshire Stock Ends Quarter on Sour Note. It's About Even With S&P 500 So Far in 2025. -- Barrons.com

2025-06-30 20:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2025-06-30 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-06-30 19:46; UTC

Rinkos pokalbiai

Nike's Buzz is Back Amid Lean into Women Sports -- Market Talk

2025-06-30 19:16; UTC

Rinkos pokalbiai

Oil Futures Snap Winning Streak on OPEC+ Outlook -- Market Talk

2025-06-30 19:10; UTC

Rinkos pokalbiai

U.S. Natural Gas Wipes Out Friday's Gains -- Market Talk

2025-06-30 19:07; UTC

Rinkos pokalbiai

Dollar Ends Losing Quarter Facing Downward Pressure -- Market Talk

2025-06-30 18:27; UTC

Rinkos pokalbiai

Gold Has Largest Half-Year Gain Since 2007 -- Market Talk

2025-06-30 17:08; UTC

Įsigijimai, susijungimai, perėmimai

MicroStrategy Stock Jumps After Latest Bitcoin Purchase as Holdings Near 600,000 Tokens -- Barrons.com

2025-06-30 17:00; UTC

Įsigijimai, susijungimai, perėmimai

HPE Stock Soars as Juniper Merger Gets Regulatory Approval. There's Just 1 Catch. -- Barrons.com

2025-06-30 16:41; UTC

Rinkos pokalbiai

WTI Crude Undeperforms as U.S.-Canada Trade Talks to Resume -- Market Talk

2025-06-30 16:32; UTC

Rinkos pokalbiai

United Parks' Potential Buyback Resumption Could Be Catalyst For Stock -- Market Talk

2025-06-30 16:23; UTC

Įsigijimai, susijungimai, perėmimai

BBVA: Offer Remains in Effect in Accordance With Applicable Regulations

2025-06-30 16:22; UTC

Įsigijimai, susijungimai, perėmimai

BBVA Decided Not to Withdraw Offer for Banco De Sabadell

2025-06-30 16:20; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2025-06-30 16:20; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Tech, Media & Telecom Roundup: Market Talk

2025-06-30 16:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2025-06-30 16:07; UTC

Uždarbis

Umicore to Post 1H Results on Aug 1

2025-06-30 15:59; UTC

Rinkos pokalbiai

Copper Conditions Set to Remain Tight But Risks Loom -- Market Talk

2025-06-30 15:55; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Home Depot to Consolidate Pro Distribution with GMS Deal -- Market Talk

2025-06-30 15:54; UTC

Rinkos pokalbiai

Gold Futures Recoup Some Losses Though Demand Looks Set to Weaken -- Market Talk

2025-06-30 15:41; UTC

Įsigijimai, susijungimai, perėmimai

Google Bets Big on Nuclear Fusion With MIT Spinoff Commonwealth -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Coloplast A-S (Class B) Prognozė

Kainos tikslas

By TipRanks

11.86% į viršų

12 mėnesių prognozė

Vidutinis 901.38 DKK  11.86%

Aukščiausias 1,056 DKK

Žemiausias 720 DKK

Remiantis 8 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Coloplast A-S (Class B) kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

8 ratings

2

Pirkti

4

Laikyti

2

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.